Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ABUS: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ABUS
Arbutus Biopharma Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ABUS
Arbutus Biopharma Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 502d
Method
›
Moved together
LLY
with
ABUS
×0.30
co-movement · ABUS on LLY · 502d
r 0.26
scale to r 0.75
No shared co-movers.
LLY, solid
ABUS, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ABUS
Arbutus Biopharma Corp
Change
3.66
▼
−9.85%
· post 3.62
Closed
Nov 5 '26
Mkt cap
$803.3M
Revenue
$1M
Q2 FY26
Revenue
$14M
FY25
vs
Compare
Closed
Nov 5 '26
LLY
ELI Lilly & Co
vs
ABUS
Arbutus Biopharma Corp
1,371.32
▼
−3.29%
post 1,363.77
Price
3.66
▼
−9.85%
post 3.62
$1.2T
Mkt cap
$803.3M
Q3 FY26
$24.4B
Revenue
$1M
Q2 FY26
FY25
$65.2B
Revenue
$14M
FY25
Change
Change
LLY
1,371.32
▼
−3.29%
vs
ABUS
3.66
▼
−9.85%
Closed
Nov 5 '26